MedTrace Logo

Safety and Efficacy of Adjustable Gastric Band Operations for Patients With Body Mass Index (BMI) Between 30-40 kg/m2

NCT00580502 · Status: COMPLETED · Phase: PHASE2/PHASE3 · Type: INTERVENTIONAL · Enrollment: 50

Last updated 2015-03-23

Study results available
· View outcomes & findings →

Summary

This study is to evaluate the safety and efficacy of Gastric Banding for patients with body mass index (BMI) between 30-40 kg/m2 with medical conditions related to obesity.

Conditions

Interventions

DEVICE

LAP-BAND® Adjustable Gastric Band (LAGB®)

Bariatric surgery for patient whose BMI is between 30 and 40 kg/m\^2

Sponsors & Collaborators

Principal Investigators

  • Christine Ren-Fielding, M.D. · NYUSOM

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
60 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2004-03-31
Primary Completion
2012-09-30
Completion
2012-09-30

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00580502 on ClinicalTrials.gov